Business programme

Stress Testing National Healthcare Systems

03 Jun , 17:00–18:15
Joining Forces to Advance Development
Congress Centre, conference hall D3
In partnership with Philips

The trauma caused by the pandemic of 2020 has highlighted the global challenge of addressing problems in national healthcare systems, many of which were found to be lacking in terms of being able to adequately respond. Meanwhile, people with acute and chronic conditions were forced to go without proper and timely treatment. Governments the world over now need to take stock of the situation in light of the events of the past year. It is vital to consolidate efforts to develop effective steps aimed at modernizing national healthcare systems. These should be based on principles of resilience, safety, and flexibility. And while it is important the ensure that the resources are in place to defeat COVID-19, healthcare systems must also be structured so that people have rapid and uninterrupted access to high-quality and full medical care. Today, international solidarity is key to improving humanity’s resilience to epidemics and other disasters. No one person can ever be completely safe, and not everyone is out of danger yet. What are the main features of an effective and resilient healthcare system today, and what might be the optimum models for the future? What initiatives set up during the pandemic warrant further development? How could a global information system informing the general public of potential risks be set up, and why is such a system necessary? What Russian crisis response models could be adapted and applied in other countries?

Elena Aksenova, Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Peter Goldschmidt, Chief Executive Officer, STADA Arzneimittel AG
Venkatesh Varma Datla Bala, Ambassador of the Republic of India to the Russian Federation
Hans Henri P. Kluge, Regional Director for Europe, World Health Organization
Maxim Kuznetsov, Market Leader Philips Central Eastern Europe & Russia, Senior Vice President
Mikhail Murashko, Minister of Health of the Russian Federation
Asgar Rangoonwala, Managing Director, Emerging Markets, Janssen Pharmaceutical Companies of Johnson & Johnson (online)
Guzel Ulumbekova, Head, Higher School of Healthcare Organization and Management
Matthias Schepp, Chairman, Russian-German Chamber of Commerce; Delegate of the Delegation of German Industry and Commerce in the Russian Federation